The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Low-dose metronomic topotecan and pazopanib in children with recurrent or refractory solid tumors: A C17 Canadian phase I trial (TOPAZ).
 
Arif Manji
No Relationships to Disclose
 
Daniel A. Morgenstern
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Clarity Pharmaceuticals; EUSA Pharma; Roche; Ymabs Therapeutics Inc
Speakers' Bureau - Ymabs Therapeutics Inc
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - EUSA Pharma
 
Yvan Samson
Consulting or Advisory Role - Bayer
Research Funding - Merck (Inst)
 
Rebecca Deyell
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - Bayer
 
Donna Johnston
No Relationships to Disclose
 
Victor Anthony Lewis
Consulting or Advisory Role - Novartis Canada Pharmaceuticals Inc
 
Alexandra Patricia Zorzi
Consulting or Advisory Role - Bayer; Bayer
 
Jason N. Berman
Employment - Children's Hospital of Eastern Ontario Research Institute
Leadership - Children's Hospital of Eastern Ontario Research Institute
 
Kathy Brodeur-Robb
No Relationships to Disclose
 
Ellen Morrison
No Relationships to Disclose
 
Sylvain Baruchel
No Relationships to Disclose
 
James A. Whitlock
Honoraria - Amgen
Consulting or Advisory Role - Jazz Pharmaceuticals
Research Funding - Novartis